Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology (Digital PCR (dPCR) and Quantitative PCR (qPCR)); Product (Reagents & Consumables, Instruments, and Software and Services); Application (Clinical Application, Research Application, and Forensic Application) and Geography

  • THE3206875
  • 159 Pages
  • November 2018
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
In the report the dPCR and qPCR market, the market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2017-2025.

The dPCR and qPCR market is driven by the driving factor such as increasing incidence of genetic diseases, growth in investments & funds for dPCR and qPCR techniques and gene synthesis, increasing number of start-up companies and technological developments in PCR technologies are likely to drive the market in the coming years. The market is likely to restrain its growth due to the factors such as technical limitations associated with qPCR and high cost of PCR systems. Whereas the increasing trend of developing droplet digital PCR for various applications are likely to propel the growth of the market.

The dPCR and qPCR market as per the technology the segment is segmented as Digital PCR (dPCR) and Qualitative PCR (qPCR). The market of qPCR has the highest market share in 2017, contributing a market share of 55.9% and is expected to retain its dominance during the forecast period from 2018 to 2025. The higher acceptance of the qPCR procedure for the molecular diagnostics and research are likely to propel the dPCR and qPCR market in the coming future. Likewise the dPCR contributed 44.1% of the market share in the year 2017 and is expected to be the fastest growing market in the coming near future.

The product segment of the dPCR and qPCR market includes reagents & consumables, instruments, and software and services. The reagents & consumables segment for the dPCR and qPCR market was valued at US$ 1,515.4 Mn in 2017 and is estimated to grow at a CAGR of 9.3% during the forecast period from 2017 to 2025, to reach US$ 3,015.0 Mn by 2025. The reagents & consumables segments is likely to dominate the market in the coming future as they are the basic requirement of researchers or healthcare professionals to conduct diagnosis or research. The software and services segments are the fastest growing segment in the product as these are extensively used for the dPCR and qPCR projects. The segment is expected to be the fastest growing segment in the forecast period.

Some of the major primary and secondary sources included in the report dPCR and qPCR market are Biotechnology Innovation Organization (BIO), Collaborative Research Programme (CRP Synthetic Biology Leadership Council, Industrial Biotechnology Leadership Forum (IBLF), Centers for Disease Control and Prevention, Department of Biotechnology, Postillion Convention Centre WTC, National Center for Biotechnology Information, Institute of Chemical Biology, National Reference Laboratory (NRL), World Health Organization, European Union, Food and Drug Administration and more.

TABLE OF CONTENTS

1. INTRODUCTION 21

1.1 SCOPE OF THE STUDY 21

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 21

2. GLOBAL DPCR AND QPCR MARKET - KEY TAKEAWAYS 22

3. GLOBAL DPCR AND QPCR MARKET - MARKET LANDSCAPE 25

3.1 OVERVIEW 25

3.2 MARKET SEGMENTATION 25

3.2.1 Global dPCR and qPCR market - By Technology 26

3.2.2 Global dPCR and qPCR market - By Product 26

3.2.3 Global dPCR and qPCR market - By Application 26

3.2.4 Global dPCR and qPCR market - By Geography 26

3.4 PEST ANALYSIS 28

3.4.1 North America - PEST Analysis 28

3.4.2 Europe- PEST Analysis 30

3.4.3 Asia Pacific - PEST Analysis 32

3.4.4 Middle East & Africa - PEST Analysis 34

3.4.5 South & Central America - PEST Analysis 36

4. GLOBAL DPCR AND QPCR MARKET - KEY MARKET DYNAMICS 38

4.1 KEY MARKET DRIVERS 38

4.1.1 Increasing Incidence of Genetic Diseases 38

4.1.2 Increase in Investments & Funds for Gene Synthesis 38

4.1.3 Technological Advancements in PCR Technologies 39

4.2 KEY MARKET RESTRAINTS 40

4.2.1 High Costs of PCR Systems 40

4.2.2 Technical Limitations Associated with qPCR 40

4.3 KEY MARKET OPPORTUNITIES 41

4.3.1 Growing adoption of PCR methods in Emerging countries 41

4.4 FUTURE TRENDS 41

4.4.1 Development of Droplet Digital PCR (ddPCR). 41

4.5 IMPACT ANALYSIS 42

5. DPCR AND QPCR MARKET - GLOBAL ANALYSIS 43

5.1 GLOBAL DPCR AND QPCR MARKET REVENUE FORECASTS AND ANALYSIS 43

5.2 GLOBAL DPCR AND QPCR MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 44

5.3 MARKET POSITIONING 45

5.4 PERFORMANCE OF KEY PLAYERS 45

5.4.1 Thermo Fisher Scientific, Inc. 45

5.4.2 F. Hoffmann-La Roche Ltd 45

5.5 EXPERT OPINIONS 46

6. GLOBAL DPCR AND QPCR MARKET ANALYSIS - BY TECHNOLOGY 47

6.1 OVERVIEW 47

6.2 DIGITAL PCR (DPCR) MARKET 48

6.2.1 Overview 48

6.2.2 Global Digital PCR (dPCR) Market Revenue and Forecasts to 2025 (US$ Mn) 48

6.3 QUANTITATIVE PCR (QPCR) MARKET 49

6.3.1 Overview 49

6.3.2 Global Quantitative PCR (qPCR) Market Revenue and Forecasts to 2025 (US$ Mn) 49

7. GLOBAL DPCR AND QPCR MARKET ANALYSIS - BY PRODUCT 50

7.1 OVERVIEW 50

7.2 REAGENTS & CONSUMABLES MARKET 50

7.2.1 Overview 50

7.2.2 Global Reagents and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 51

7.3 INSTRUMENTS MARKET 52

7.3.1 Overview 52

7.3.2 Global Instruments Market Revenue and Forecasts to 2025 (US$ Mn) 52

7.4 SOFTWARE & SERVICES MARKET 53

7.4.1 Overview 53

7.4.2 Global Software & Services Market Revenue and Forecasts to 2025 (US$ Mn) 53

8. GLOBAL DPCR AND QPCR MARKET ANALYSIS- BY APPLICATION 54

8.1 OVERVIEW 54

8.2 GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 54

8.2.1 Clinical Application Market 54

8.2.1.1 Overview 54

8.2.1.2 Global Clinical Application Market Revenue And Forecasts To 2025 (US$ Mn) 54

8.2.1.3 Pathogen Testing Market 56

8.2.1.3.1 Overview 56

8.2.1.3.2 Global Pathogen Testing Market Revenue And Forecasts To 2025 (US$ Mn) 56

8.2.1.4 Oncology Testing Market 57

8.2.1.4.1 Overview 57

8.2.1.4.2 Global Oncology Testing Market Revenue And Forecasts To 2025 (US$ Mn) 57

8.2.1.5 Blood Screening Testing Market 57

8.2.1.5.1 Overview 57

8.2.1.5.2 Global Blood Screening Testing Market Revenue And Forecasts To 2025 (US$ Mn) 58

8.2.2 Research Application Market 58

8.2.2.1 Overview 58

8.2.2.2 Global Research Application Market Revenue And Forecasts To 2025 (US$ Mn) 58

8.2.3 Forensic Application Market 59

8.2.3.1 Overview 59

8.2.3.2 Global Forensic Application Market Revenue And Forecasts To 2025 (US$ Mn) 59

9. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 61

9.1 OVERVIEW 61

9.2 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62

9.3 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 62

9.3.1 North America dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 62

9.3.2 North america dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 62

9.3.3 North america Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 63

9.4 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63

9.5 US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64

9.5.1 US dPCR and qPCR Market Revenue and Forecasts to 2025 (US$ Mn) 65

9.5.2 US dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 65

9.5.3 US dPCR and qPCR market Revenue And Forecasts to 2025, By Product (US$ Mn) 65

9.5.4 US dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66

9.5.5 US Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 66

9.6 CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67

9.6.1 Canada dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 67

9.6.2 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 68

9.6.3 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68

9.6.4 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 68

9.6.5 Canada Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 69

9.7 MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70

9.7.1 Mexico DPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 70

9.7.2 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 71

9.7.3 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71

9.7.4 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 71

9.7.5 Mexico Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72

10. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 73

10.1 OVERVIEW 73

10.2 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74

10.3 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 74

10.3.1 Europe dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74

10.3.2 Europe dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74

10.3.3 Europe Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 75

10.4 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 75

10.5 UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76

10.5.1 UK dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 77

10.5.2 UK dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 77

10.5.3 UK dPCR and qPCR market Revenue And Forecasts to 2025, By Product (US$ Mn) 77

10.5.4 UK dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 78

10.5.5 UK Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78

10.6 GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79

10.6.1 Germany dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 80

10.6.2 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 80

10.6.3 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 80

10.6.4 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81

10.6.5 Germany Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 81

10.7 FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82

10.7.1 France dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 83

10.7.2 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 83

10.7.3 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 83

10.7.4 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84

10.7.5 France Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 84

11. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 85

11.1 OVERVIEW 85

11.2 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86

11.3 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 86

11.3.1 Asia Pacific dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 86

11.3.2 Asia Pacific dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86

11.3.3 Asia Pacific Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 87

11.4 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 87

11.5 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88

11.5.1 China dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 88

11.6 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 88

11.6.1 China dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 89

11.6.2 China dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89

11.6.3 China Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 89

11.7 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89

11.7.1 Japan dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 90

11.8 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 90

11.8.1 Japan dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90

11.8.2 Japan dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91

11.8.3 Japan Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 91

11.9 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92

11.9.1 India dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 92

11.10 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 92

11.10.1 India dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93

11.10.2 India dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93

11.10.3 India Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 93

12. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 94

12.1 OVERVIEW 94

12.2 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95

12.3 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 95

12.3.1 Middle East and Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 95

12.3.2 Middle East and Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 96

12.3.3 Middle East and Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 96

12.4 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 96

12.6 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98

12.6.1 UAE dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 98

12.7 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 98

12.7.1 UAE dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 99

12.7.2 UAE dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 99

12.7.3 UAE Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 99

12.8 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99

12.8.1 Saudi Arabia dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 100

12.9 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 100

12.9.1 Saudi Arabia dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 101

12.9.2 Saudi Arabia dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 101

12.9.3 Saudi Arabia Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 101

12.10 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

12.10.1 South Africa dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 102

12.11 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 102

12.11.1 South Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103

12.11.2 South Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 103

12.11.3 South Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 103

13. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 104

13.1 OVERVIEW 104

13.2 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105

13.3 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 105

13.3.1 South and Central America dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 105

13.3.2 South and Central America dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106

13.3.3 South and Central America Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 106

13.4 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 106

13.5 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107

13.5.1 Brazil dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 107

13.6 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 107

13.6.1 Brazil dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108

13.6.2 Brazil dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 108

13.6.3 Brazil Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 108

14. DPCR AND QPCR MARKET -KEY COMPANY PROFILES 110

14.1 ABBOTT 110

14.1.1 Key Facts 110

14.1.2 Business Description 110

14.1.3 Financial Information 111

14.1.4 Product Portfolio 111

14.1.5 SWOT Analysis 111

14.1.6 Key Developments 113

14.2 F. HOFFMANN-LA ROCHE LTD. 114

14.2.1 Key Facts 114

14.2.2 Business Description 114

14.2.3 Financial Overview 115

14.2.4 Product Portfolio 115

14.2.5 Swot Analysis 116

14.2.6 Key Developments 117

14.3 THERMO FISHER SCIENTIFIC, INC. 118

14.3.1 Key Facts 118

14.3.2 Business Description 118

14.3.3 Financial Information 119

14.3.4 Product Portfolio 119

14.3.5 SWOT Analysis 120

14.3.6 Key Developments 121

14.4 BIO-RAD LABORATORIES, INC. 122

14.4.1 Key Facts 122

14.4.2 Business Description 122

14.4.3 Financial Information 123

14.4.4 Product Portfolio 123

14.4.5 SWOT Analysis 123

14.4.6 Key Developments 124

14.5 QIAGEN 126

14.5.1 Key Facts 126

14.5.2 Business Description 126

14.5.3 Financial Overview 126

14.5.4 Product Portfolio 127

14.5.5 Swot Analysis 128

14.5.6 Key Developments 129

14.6 TAKARA BIO, INC. 130

14.6.1 Key Facts 130

14.6.2 Business Description 130

14.6.3 Financial Information 131

14.6.4 Product Portfolio 131

14.6.5 SWOT Analysis 132

14.6.6 Key Developments 133

14.7 AGILENT TECHNOLOGIES, INC. 135

14.7.1 Key Facts 135

14.7.2 Business Description 135

14.7.3 Financial Information 136

14.7.4 Product Portfolio 136

14.7.5 SWOT Analysis 137

14.7.6 Key Developments 138

14.8 BIOMÉRIEUX SA 139

14.8.1 Key Facts 139

14.8.2 Business Description 139

14.8.3 Financial Information 140

14.8.4 Product Portfolio 140

14.8.5 SWOT Analysis 141

14.8.6 Key Developments 142

14.9 DANAHER 143

14.9.1 Key Facts 143

14.9.2 Business Description 143

14.9.3 Financial Overview 143

14.9.4 Product Portfolio 144

14.9.5 Swot Analysis 144

14.9.6 Key Developments 146

14.10 FLUIDIGM CORPORATION 147

14.10.1 Key Facts 147

14.10.2 Business Description 147

14.10.3 Financial Overview 148

14.10.4 Product Portfolio 148

14.10.5 Swot Analysis 149

14.10.6 Key Developments 150

15. APPENDIX 152

15.1 ABOUT THE INSIGHT PARTNERS 152

15.2 GLOSSARY OF TERMS 153

15.3 METHODOLOGY 156

15.3.1 Coverage 157

15.3.2 Secondary Research 158

15.3.3 Primary Research 158

LIST OF TABLES

TABLE 1. NORTH AMERICA AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 63

TABLE 2. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 63

TABLE 3. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64

TABLE 4. NORTH AMERICA AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 64

TABLE 5. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66

TABLE 6. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 66

TABLE 7. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67

TABLE 8. US CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 67

TABLE 9. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69

TABLE 10. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 69

TABLE 11. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69

TABLE 12. CANADA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 70

TABLE 13. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72

TABLE 14. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 72

TABLE 15. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72

TABLE 16. MEXICO CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 73

TABLE 17. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75

TABLE 18. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 75

TABLE 19. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76

TABLE 20. EUROPE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 76

TABLE 21. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78

TABLE 22. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78

TABLE 23. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79

TABLE 24. UK CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 79

TABLE 25. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81

TABLE 26. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81

TABLE 27. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82

TABLE 28. GERMANY CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 82

TABLE 29. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84

TABLE 30. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84

TABLE 31. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85

TABLE 32. FRANCE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 85

TABLE 33. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 87

TABLE 34. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87

TABLE 35. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88

TABLE 36. ASIA PACIFIC CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 88

TABLE 37. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 89

TABLE 38. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90

TABLE 39. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90

TABLE 40. CHINA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90

TABLE 41. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91

TABLE 42. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92

TABLE 43. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92

TABLE 44. JAPAN CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 92

TABLE 45. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93

TABLE 46. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94

TABLE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 94

TABLE 48. INDIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 94

TABLE 49. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 96

TABLE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96

TABLE 51. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97

TABLE 52. MIDDLE EAST AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97

TABLE 53. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 99

TABLE 54. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 100

TABLE 55. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100

TABLE 56. UAE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 100

TABLE 57. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 101

TABLE 58. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 102

TABLE 59. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102

TABLE 60. SAUDI ARABIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 102

TABLE 61. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 103

TABLE 62. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 104

TABLE 63. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104

TABLE 64. SOUTH AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 104

TABLE 65. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106

TABLE 66. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106

TABLE 67. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107

TABLE 68. SOUTH AND CENTRAL AMERICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 107

TABLE 69. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109

TABLE 70. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109

TABLE 71. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109

TABLE 72. BRAZIL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 109

TABLE 73. GLOSSARY OF TERMS, DPCR AND QPCR MARKET 154

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC DPCR AND QPCR MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 23

FIGURE 2. GLOBAL DPCR AND QPCR MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 24

FIGURE 3. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24

FIGURE 4. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24

FIGURE 5. DPCR AND QPCR MARKET SEGMENTATION 26

FIGURE 6. DPCR AND QPCR SEGMENTATION, BY REGION 27

FIGURE 7. NORTH AMERICA PEST ANALYSIS 29

FIGURE 8. EUROPE PEST ANALYSIS 31

FIGURE 9. ASIA PACIFIC PEST ANALYSIS 33

FIGURE 10. MIDDLE EAST & AFRICA PEST ANALYSIS 35

FIGURE 11. SOUTH & CENTRAL AMERICA PEST ANALYSIS 37

FIGURE 12. DPCR AND QPCR MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 43

FIGURE 13. GLOBAL DPCR AND QPCR MARKET - REVENUE FORECASTS AND ANALYSIS - 2016- 2025 44

FIGURE 14. GLOBAL DPCR AND QPCR MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 45

FIGURE 15. GLOBAL DPCR AND QPCR MARKET - MARKET POSITIONING, 2017 46

FIGURE 16. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY TECHNOLOGY, 2017 & 2025 (%) 48

FIGURE 17. GLOBAL DIGITAL PCR (DPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49

FIGURE 18. GLOBAL QUANTITATIVE PCR (QPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50

FIGURE 19. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY PRODUCT, 2017 & 2025 (%) 51

FIGURE 20. GLOBAL REAGENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52

FIGURE 21. GLOBAL INSTRUMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53

FIGURE 22. GLOBAL SOFTWARE & SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54

FIGURE 23. GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 55

FIGURE 24. GLOBAL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56

FIGURE 25. GLOBAL PATHOGEN TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57

FIGURE 26. GLOBAL ONCOLOGY TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58

FIGURE 27. GLOBAL BLOOD SCREENING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59

FIGURE 28. GLOBAL RESEARCH APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59

FIGURE 29. GLOBAL FORENSIC APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60

FIGURE 30. NORTH AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 62

FIGURE 31. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63

FIGURE 32. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 64

FIGURE 33. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66

FIGURE 34. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68

FIGURE 35. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71

FIGURE 36. EUROPE DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 74

FIGURE 37. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75

FIGURE 38. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76

FIGURE 39. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78

FIGURE 40. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81

FIGURE 41. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84

FIGURE 42. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86

FIGURE 43. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87

FIGURE 44. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88

FIGURE 45. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89

FIGURE 46. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91

FIGURE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93

FIGURE 48. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95

FIGURE 49. MIDDLE EAST AND AFRICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96

FIGURE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 97

FIGURE 51. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99

FIGURE 52. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

FIGURE 53. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103

FIGURE 54. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 105

FIGURE 55. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106

FIGURE 56. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 107

FIGURE 57. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750